Cabaletta Bio

This study is testing a single dose of an experimental cell therapy called CABA-201 for adults and children with active autoimmune muscle diseases, like dermatomyositis. The therapy uses the patient's own modified immune cells (CAR T-cells) to target and remove harmful B cells th…

This study is testing an experimental cell therapy called CABA-201 for adults with active lupus. Doctors will collect a patient's own immune cells, modify them to target the harmful cells causing lupus, and infuse them back. The main goals are to see if this one-time treatment is…

This study is testing two new cell therapies for adults with active pemphigus vulgaris, a painful autoimmune disease that causes severe blisters. Researchers are giving patients their own immune cells that have been specially engineered in a lab to target and potentially control …

This early-stage study is testing a single dose of an experimental cell therapy called CABA-201 for adults with active systemic sclerosis (scleroderma). The therapy, known as CAR T-cell therapy, is designed to target and remove a type of immune cell (B cells) thought to drive the…